XNAS: ACTU
Actuate Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglu...
Read More
2.56
-0.21
(-7.58%)
37,800.3
XNAS Volume
XNAS 18 Mar, 2026 3:13 PM (EDT)
Board Meeting
The next board meeting for Actuate Therapeutics Inc is on 20 Mar 2026 for the purpose of Actuate Therapeutics Inc Annual Report for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
Actuate Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..